Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer. (Q40305237)
Jump to navigation
Jump to search
scientific article published on December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer. |
scientific article published on December 2011 |
Statements
Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer (English)
Hui-Yan Luo
Zhi-Qiang Wang
Feng-Hua Wang
Miao-Zhen Qiu
Kai-Yuan Teng
Dan-Yun Ruan
You-Jian He